The Velocity team had the honor of hosting former U.S. Surgeon General and Chairman of the Board of TOTAL Diversity Clinical Trial Management, Jerome Adams, MD, MPH. He joined an internal call to discuss the importance of diversity in clinical research, highlighting the need for diverse patient populations in clinical trials to ensure new treatments … Read more
The narrative that’s been peddled for the past three decades has seen obesity become mired in controversy, leading many – even healthcare professionals – to view it as a lifestyle choice rather than a disease. Nearly 40% of the global population has a body mass index (BMI) higher than 25 kg/m2, meaning they’re overweight or … Read more
We can talk about elevating the patient’s voice in clinical research, or we can listen. So let’s listen! In this clip, you’ll hear from both current and past clinical trial participants. They share their first encounters with clinical research and the reasons they decided to participate. This compilation is from a recent Velocity Participant Advisory … Read more
Velocity is using multimodal LLMs, like OpenAI’s GPT-4o and others, to enhance productivity. At the forefront of this shift is Raghu Punnamraju, Velocity’s Chief Technology Officer. In this article he shares his thoughts on the rapid evolution of LLMs, and how quickly new tools are being applied to improve quality and efficiency. We have been anticipating … Read more
Enjoy a virtual tour of Velocity’s Durham, NC site, which showcases many of the features and standard equipment present at Velocity sites worldwide. Standard Velocity site features: Private exam rooms Comfortable patient reception areas Facilities for extended-stay PK studies Ample parking Secure monitoring rooms and workstations equipped with phones and high-speed internet Individual and secure … Read more
“Next to clean water, vaccines are probably responsible for more saved lives than anything else we’ve done in medicine.” -Mark Turner, MD, Vaccine CARE Council Leader and Velocity Principal Investigator in Boise, ID. Given the constant evolution of viruses and the massive medical and economic burdens imposed by viral diseases, vaccine research remains a global … Read more
Beth Safirstein, MD, leads a site that was recently recognized by a top 10 pharma Sponsor as a leading U.S. enroller of diverse patients. As the chair of the CNS CARE Council, Dr. Safirstein is one of the expert Principal Investigators who will inform the way Velocity sites shape and share best practices to reach … Read more
“Clinical research is really the only opportunity we have to give our patients some hope and some perspective that their disease will one day be treatable.” Nadege Gunn, MD, CPI, has consistently championed community engagement and physician referrals to drive successful clinical trial enrollment at her site in Waco, TX. As a MASH CARE Council … Read more
Velocity recently asked some key employees to come together and discuss a wide array of issues impacting diversity, equity, and inclusion (DEI) in trials. Velocity’s ongoing goals are to share best practices, identify and address shortcomings, and bring as many perspectives and viewpoints to the table as possible to advance clinical trials and deliver vital … Read more
To celebrate the upcoming Clinical Trials Day and the ‘Trailblazers Among Us’ theme, Paul Evans, President and CEO of Velocity, and Victoria DiBiaso, Head, Patient Informed Development & Health Value Translation at Sanofi, have coauthored this article. In the post, they review several of the opportunities and challenges inherent in shaping a better future for … Read more